1Biesen WV ,Yeys N, Vanholder N, et al. The role of APD in an ESRD program[J]. Seminars in Dialysis, 2002, 6: 422-426.
2Li PK, Chow KM. Maximizing the success of peritoneal dialysis in hightransporters[J].Perit Dia Int, 2007,27: S148- S152.
3Cueto-Manzano AM, Rojas-Campos E, Martinez-Ramirez HR, et al. Can the inflammation markers of patients with high Perito neal pemeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis[J]? Petit Dial lnt, 2006, 26:341-348.
4Dives SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients:Results of a double-blind randomized controlled trial[J]. J Am Soc Nephrol ,2003, 14:2338-2344.
5Finkelstein F, Healy H, Abu Alfa, Ahmad S , et al. Superiority of icodextrin compared with 4. 25% dextrose for peritoneal ultrafiltration[J].J Am Soc Nephrol, 2005,16:546 554.
6Li PK, Cheng YL. Therapeutic options for presrvation of residual renal function in patients on peritoneal dialysis [J].Perit Dia Int , 2007,27:S158 -S163.
7Rabindranath K S, Adams J, Ali T Z ,et al. Automated vs continuous ambulatory peritoneal dialysis a systematic review of randomized controlled trials[J]. Nephrol Dial Transplant, 2007,22: 2991-2998.
8Verger C, Ryckelynck J-P, Duman M, et al. French peritoneal dialysis registry (RDPLF): Outline and main results[J]. Kidney International, 2006, 70:S12-S20.
9Yelasco RF, Munoz 3 L, Saavedra V S, et al. Automated peritoneal dialysis as the modality of choice: A singlecenter, 3-year experience with 458 children in Mexico[J]. Pediatr Nephrol, 2008,23:465- 471.
1Maiorca R,Branori G,Zubani R,et al.Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients.A longitudinal study[J].Nephrol Dial Transplant,1995,10:2295-2305.
2Wang AY,Wang M,Woo J,et al.Inflammation,residual kidney function,and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients[J].J Am Soc Nephrol,2004,15:2186-2194.
3Adequacy of dialysis and nutrition in continuous peritoneal dialysis:association with clinical outcomes.Canada朥SA (CANUSA) Peritoneal Dialysis Study Group[J].J Am Soc Nephro1,1996,7:198-107.
4Bargman JM,Thorpe KE,Churchill DN.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis:a reanalysis of the CANUSA study[J].J Am Soc Nephrol,2001,12:2158-2162.
5Paniagua R,Amato D,Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis:ADEMEX,a prospective,randomized,controlled trial[J].J Am Soc Nephrol,2002,13:1307-1320.
6Wang AY,Woo J,Wang M,et al.Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function[J].Nephrol Dial Transplant,2005,20:396-303.
7Ates K,Nergizoglu G,Keven K,et al.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients[J].Kidney Int,2001,60:767-776.
8Wang AY,Sanderson J,Sea MM,et al.Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis[J].Am J Clin Nutr,2003,77:834-841.
9Menon MK,Naimark DM,Bargman JM,et al.Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function[J].Nephrol Dial Transplant,2001,16:2207-2213.
10Levin A,Thompson CR,Ethier J,et al.Left ventricular mass index increase in early renal disease:impact of decline in hemoglobin.Am J Kidney Dis,1999,34:125-134.
7Taskapan H, Senel S, Ulutas O, et al. homocysteine levels in pa- tients with end- stage renal failure with regard to dialysis modali- ty. J Ren Fail,2006,28:303 -308.
8Mitsnefes MM, Kimball TR, Kartal J, et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role ofcalcium - phosphorus metabolism. J Am Soc Nephrol, 2005,16 : 2796 - 2803.
9Heinz J, Kropf S, Luley C, et al. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis : a meta - anal- ysis. Am J Kidney Dis ,2009,54:478 - 479.
10Ferechide D, Radulescu D. Hyperhomocysteinemia in renal disea- ses. J Med Life,2009,2:53 -59.
